CSIMarket
 
Inmode Ltd   (NASDAQ: INMD)
Other Ticker:  
 
 
Price: $16.7900 $0.22 1.328%
Day's High: $16.805 Week Perf: 5.13 %
Day's Low: $ 16.42 30 Day Perf: -6.57 %
Volume (M): 1,006 52 Wk High: $ 26.80
Volume (M$): $ 16,887 52 Wk Avg: $18.54
Open: $16.68 52 Wk Low: $14.87



 Market Capitalization (Millions $) 1,443
 Shares Outstanding (Millions) 86
 Employees 400
 Revenues (TTM) (Millions $) 492
 Net Income (TTM) (Millions $) 198
 Cash Flow (TTM) (Millions $) 47
 Capital Exp. (TTM) (Millions $) 1

Inmode Ltd
Inmode Ltd is a global technology company that specializes in developing, manufacturing, and marketing innovative medical devices for the aesthetic market. The company was founded in 2008 and is headquartered in Yokneam, Israel, with additional offices and subsidiaries in the United States, China, Japan, and Europe.

Inmode's products are designed to address a wide range of aesthetic concerns, including skin aging, body contouring, hair removal, vascular lesions, and more. The company's flagship technology is the InMode Platform, an advanced radiofrequency-based platform that offers a wide range of treatment configurations and can be used for both surgical and non-surgical procedures.

The company has developed several innovative products that have been approved by regulatory bodies in various countries. These products include:

1. BodyTite - a minimally-invasive body contouring device that uses radiofrequency energy to melt fat and tighten skin.

2. FaceTite - a non-surgical facelift device that uses the same radiofrequency technology as BodyTite to lift and tighten sagging skin on the face and neck.

3. Morpheus8 - a microneedling device that combines radiofrequency energy with fractional technology to stimulate collagen production and improve skin texture and tone.

4. DiolazeXL - a diode laser hair removal device that offers fast, safe and effective treatment for all skin types and hair textures.

5. Votiva - a vaginal rejuvenation device that uses radiofrequency energy to improve sexual function and restore vaginal tissue.

Inmode's products have gained popularity among cosmetic surgeons and dermatologists due to their innovative technology, effectiveness, and safety. The company's business strategy is built on a direct sales model, and it has a strong global distribution network, with sales in over 100 countries worldwide.

In addition to its innovative products, Inmode is also known for its commitment to research and development. The company invests heavily in clinical research and has published numerous studies in peer-reviewed journals, providing scientific evidence to support the safety and effectiveness of its products.

Overall, Inmode Ltd is a leading player in the aesthetic device industry, continually developing innovative products that offer safe and effective solutions for patients around the world.


   Company Address: Tavor Building Yokneam 2069206
   Company Phone Number: 4-9096313   Stock Exchange / Ticker: NASDAQ INMD


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BDX        0.5% 
BSX        4.28% 
CUTR        18.83% 
ESTA        2.52% 
MDXG        6.54% 
OSUR   -1.35%    
• View Complete Report
   



Announcement

InMode Ltd. Faces Securities Class Action Lawsuit, Investors Encouraged to Submit Losses

Published Sat, Apr 13 2024 3:44 PM UTC

InMode Ltd. (NASDAQ: INMD), a global leader in medical aesthetic solutions, is currently facing a securities class action lawsuit. Hagens Berman, a renowned national trial attorney firm, is urging all investors who purchased INMD stock during the class period and incurred losses of at least $100,000 to come forward and submit their losses before the April 15th deadline.The s...

Announcement

InMode Ltd. Faces Shareholder Class Action Lawsuit: Assessing the Impact on the Company

Published Sat, Mar 23 2024 2:30 PM UTC

InMode Ltd. (NASDAQ: INMD), a prominent medical technology company, finds itself in the midst of a class action lawsuit filed by investors. Pomerantz LLP, a renowned law firm, has taken legal action against the company, citing concerns and potential damages that may have afflicted shareholders.The class action lawsuit alleges that InMode Ltd. and its executives have engaged ...

Inmode Ltd

Impressive Surge: INMDsn Unveils Robust Revenue Growth in Fourth Quarter of 2023

Inmode Ltd, a leading Medical Equipment & Supplies company, has demonstrated remarkable growth and success in its recent financial report. The company's revenue for the fiscal year ending December 31, 2023, increased by an impressive 8.316% to reach $492.05 million, compared to $454.27 million in the previous year.
One notable achievement for Inmode Ltd is its profits growth of 21.69%, with earnings per share rising to $2.30 from $1.89 in the prior year quarter. This indicates that the company has outperformed its contemporaries in the Medical Equipment & Supplies sector, which only showed a revenue growth of 4.26% during the same period.










Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com